Teligent is a specialty generic pharmaceutical company (NASDAQ: TLGT). Our mission is to be a leading player in the specialty generic prescription drug market. 

We currently have 32 topical Abbreviated New Drug Applications (ANDAs) on file at the FDA, representing a total addressable market of approximately $2.0 billion (IMS, March 2017).  

We sell a portfolio of prescription topical medicines and a growing number of hospital-based sterile injectable products, including cephalosporins.

Click to view the Teligent corporate presentation:

Jenniffer Collins, CFO

‘’As we grow, we will keep our focus on execution, ownership and delivering on what we promise.’’

print email
Price Data